Your browser doesn't support javascript.
loading
Oral administration of nano-emulsion curcumin in mice suppresses inflammatory-induced NFκB signaling and macrophage migration.
Young, Nicholas A; Bruss, Michael S; Gardner, Mark; Willis, William L; Mo, Xiaokui; Valiente, Giancarlo R; Cao, Yu; Liu, Zhongfa; Jarjour, Wael N; Wu, Lai-Chu.
Affiliation
  • Young NA; Division of Rheumatology and Immunology, Wexner Medical Center at The Ohio State University, Columbus, Ohio, United States of America; Department of Internal Medicine, Wexner Medical Center at The Ohio State University, Columbus, Ohio, United States of America.
  • Bruss MS; Division of Rheumatology and Immunology, Wexner Medical Center at The Ohio State University, Columbus, Ohio, United States of America; Department of Internal Medicine, Wexner Medical Center at The Ohio State University, Columbus, Ohio, United States of America.
  • Gardner M; Division of Rheumatology and Immunology, Wexner Medical Center at The Ohio State University, Columbus, Ohio, United States of America; Department of Internal Medicine, Wexner Medical Center at The Ohio State University, Columbus, Ohio, United States of America.
  • Willis WL; Division of Rheumatology and Immunology, Wexner Medical Center at The Ohio State University, Columbus, Ohio, United States of America; Department of Internal Medicine, Wexner Medical Center at The Ohio State University, Columbus, Ohio, United States of America.
  • Mo X; Center for Biostatistics, Wexner Medical Center at The Ohio State University, Columbus, Ohio, United States of America.
  • Valiente GR; Division of Rheumatology and Immunology, Wexner Medical Center at The Ohio State University, Columbus, Ohio, United States of America; Department of Internal Medicine, Wexner Medical Center at The Ohio State University, Columbus, Ohio, United States of America.
  • Cao Y; College of Pharmacy, Wexner Medical Center at The Ohio State University, Columbus, Ohio, United States of America.
  • Liu Z; College of Pharmacy, Wexner Medical Center at The Ohio State University, Columbus, Ohio, United States of America; Comprehensive Cancer Center, Wexner Medical Center at The Ohio State University, Columbus, Ohio, United States of America.
  • Jarjour WN; Division of Rheumatology and Immunology, Wexner Medical Center at The Ohio State University, Columbus, Ohio, United States of America; Department of Internal Medicine, Wexner Medical Center at The Ohio State University, Columbus, Ohio, United States of America.
  • Wu LC; Division of Rheumatology and Immunology, Wexner Medical Center at The Ohio State University, Columbus, Ohio, United States of America; Department of Internal Medicine, Wexner Medical Center at The Ohio State University, Columbus, Ohio, United States of America.
PLoS One ; 9(11): e111559, 2014.
Article in En | MEDLINE | ID: mdl-25369140
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: NF-kappa B / Curcumin / Macrophages / Anti-Inflammatory Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2014 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: NF-kappa B / Curcumin / Macrophages / Anti-Inflammatory Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2014 Document type: Article Affiliation country: United States